0001752724-23-152095.txt : 20230714
0001752724-23-152095.hdr.sgml : 20230714
20230714092319
ACCESSION NUMBER: 0001752724-23-152095
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 4
CONFORMED PERIOD OF REPORT: 20230430
FILED AS OF DATE: 20230714
DATE AS OF CHANGE: 20230714
EFFECTIVENESS DATE: 20230714
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXCHANGE TRADED CONCEPTS TRUST
CENTRAL INDEX KEY: 0001452937
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-22263
FILM NUMBER: 231088151
BUSINESS ADDRESS:
STREET 1: 10900 HEFNER POINTE DRIVE
STREET 2: SUITE 400
CITY: OKLAHOMA CITY
STATE: OK
ZIP: 73120
BUSINESS PHONE: 405-778-8377
MAIL ADDRESS:
STREET 1: 10900 HEFNER POINTE DRIVE
STREET 2: SUITE 400
CITY: OKLAHOMA CITY
STATE: OK
ZIP: 73120
FORMER COMPANY:
FORMER CONFORMED NAME: FAITHSHARES TRUST
DATE OF NAME CHANGE: 20090717
FORMER COMPANY:
FORMER CONFORMED NAME: FAITHSHARES INC
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: VERITAS FUNDS INC
DATE OF NAME CHANGE: 20081230
0001452937
S000042659
ROBO Global(R) Robotics and Automation Index ETF
C000131868
ROBO Global(R) Robotics and Automation Index ETF
ROBO
0001452937
S000065729
ROBO Global(R) Artificial Intelligence ETF
C000212574
ROBO Global(R) Artificial Intelligence ETF
THNQ
0001452937
S000065730
ROBO Global(R) Healthcare Technology and Innovation ETF
C000212575
ROBO Global(R) Healthcare Technology and Innovation ETF
HTEC
0001452937
S000068816
Nifty India Financials ETF
C000219897
Nifty India Financials ETF
INDF
0001452937
S000076793
KPOP and Korean Entertainment ETF
C000236828
KPOP and Korean Entertainment ETF
KPOP
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0001452937
XXXXXXXX
811-22263
N-1A
S000065729
true
S000065730
true
S000042659
true
S000076793
true
S000068816
true
EXCHANGE TRADED CONCEPTS TRUST
811-22263
0001452937
549300TXJW88BSB0KL90
10900 HEFNER POINTE DRIVE
SUITE 400
OKLAHOMA CITY
73120
US-OK
US
4057788377
SEI INVESTMENTS DISTRIBUTION CO.
1 Freedom Valley Drive
OAKS
19456
610-676-1000
Records as Distributor for Trust
Vident Investment Advisory, LLC
300 Colonial Center Parkway
Suite 330
Roswell
30076
1-404-487-1961
Records as sub-advisor for Trust
Exchange Traded Concepts, LLC
10900 Hefner Pointe Drive
SUITE 400
Oklahoma City
73120
1-405-778-8377
Records as Advisor for Trust
SEI INVESTMENTS GLOBAL FUNDS SERVICES
1 Freedom Valley Drive
OAKS
19456
610-676-1000
Records as Administrator for Trust
Bank of New York Mellon
240 Greenwich Street
New York
10286
1-212-495-1784
Records as Custodian and Transfer Agent for Trust
BROWN BROTHERS HARRIMAN & CO.
40 Water Street
Boston
02109
617-772-1818
Records as Custodian and Transfer Agent for Trust
N
N
N
N-1A
20
Y
Mark Zurack
N/A
N
Timothy Jacoby
N/A
N
Stuart Strauss
N/A
N
J. Garrett Stevens
N/A
Y
Linda Petrone
N/A
N
Matthew B. Fleischer
N/A
295 Madison Avenue
26th Floor
New York
10017
XXXXXX
N
N
N
N
N
SEI INVESTMENTS DISTRIBTUION CO.
8-27897
000010690
N/A
N
N
Cohen & Company, Ltd
925
N/A
N
N
N
N
N
N
N
ROBO Global(R) Artificial Intelligence ETF
S000065729
549300AO11OCTHSACQ26
N
1
0
0
Exchange-Traded Fund
N
N
0.36
-0.31
0.594677425
0.586921522
Y
N
Y
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N/A
0.00000000
0.00000000
Rule 6c-11 (17 CFR 270.6c-11)
Rule 32a-4 (17 CFR 270.32a-4)
N
N
N
N
Exchange Traded Concepts LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
The Bank of New York Mellon
085-05006
HPFHU0OQ28E4N0NFVK49
N
N
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
S&P
549300U4VWNITEKO2881
N
Bloomberg
254900BF4G8VMW8GG471
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
N
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
BTIG LLC
008-65473
000122225
549300GTG9PL6WO3EC51
6795.06000000
GOLDMAN, SACHS & CO.
008-00129
000000361
FOR8UP27PHTHYVLBNG30
5.24999999
PERSHING LLC
008-17574
000007560
ZI8Q1A8EI8LQFJNM0D94
147.76000000
MISCHLER FINANCIAL
8-48067
000037818
2549004IPXPSM9EJFC92
321.43999999
7269.51000000
0.00000000
N
24467918.78999999
N
N
N
ROBO Global(R) Healthcare Technology and Innovation ETF
S000065730
549300DWX5221AQZYJ12
N
1
0
0
Exchange-Traded Fund
N
N
0.02
-0.65
0.256710343
0.227797487
Y
N
Y
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N/A
0.00000000
0.00000000
Rule 32a-4 (17 CFR 270.32a-4)
Rule 6c-11 (17 CFR 270.6c-11)
N
N
N
N
Exchange Traded Concepts, LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
Bank of New York Mellon
085-05006
HPFHU0OQ28E4N0NFVK49
N
N
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
Bloomberg
254900BF4G8VMW8GG471
N
S&P
549300U4VWNITEKO2881
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
N
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
BTIG LLC
008-65473
000122225
549300GTG9PL6WO3EC51
17700.25
MISCHLER FINANCIAL
8-48067
000037818
2549004IPXPSM9EJFC92
22498.45
40198.70
0.00000000
N
108467999.40
N
N
N
ROBO Global(R) Robotics and Automation Index ETF
S000042659
549300DWX5221AQZYJ12
N
1
0
0
Exchange-Traded Fund
N
N
0.17
-0.83
0.213233752
0.177509456
Y
N
Y
N
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Administrative fee
58344139.70
748509.85
Rule 6c-11 (17 CFR 270.6c-11)
Rule 32a-4 (17 CFR 270.32a-4)
N
N
N
N
Exchange Traded Concepts, LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
Vident Investment Advisory, LLC
801-80534
000171004
254900XSZB691Z1A6X78
2023-02-10
Bank of New York Mellon
085-05006
HPFHU0OQ28E4N0NFVK49
N
N
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
S&P
549300U4VWNITEKO2881
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
Bloomberg
254900BF4G8VMW8GG471
N
N
HONGKONG AND SHANGHAI BANKING CORPORATION, HONG KONG
N/A
HK
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON SA/NV
N/A
NL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
FR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
GB
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SKANDINAVISKA ENSKILDA BANKEN, STOCKHOLM
N/A
SE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SKANDINAVISKA ENSKILDA BANKEN, HELSINKI BRANCH
N/A
FI
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
NL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CREDIT SUISSE (SWITZERLAND) LTD (T2S)
N/A
CH
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
DE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CIBC MELLON TRUST COMPANY
N/A
CA
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HSBC SHANGHAI-HONG KONG STOCK CONNECT SPSA
N/A
HK
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HSBC BANK (TAIWAN) LIMITED
N/A
TW
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
MUFG BANK, LTD
N/A
JP
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SKANDINAVISKA ENSKILDA BANKEN AB, OSLO BRANCH
N/A
NO
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON SA/NV, ASSET SERVICING, NIEDERLASSUNG FRANKFURT AM MAIN
N/A
DE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
BANK HAPOALIM B.M.
N/A
IL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
DEUTSCHE BANK-SEOUL BRANCH
N/A
KR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
FI
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
ESES FRANCE REGISTERED
N/A
FR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
EUROCLEAR BANK, BRUSSELS
N/A
BE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
ESES FRANCE BEARER
N/A
FR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CREDIT SUISSE (SWITZERLAND) LTD
N/A
CH
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
N
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
RBC CAPITAL
008-45411
000031194
549300LCO2FLSSVFFR64
3124.62
PERSHING LLC
008-17574
000007560
ZI8Q1A8EI8LQFJNM0D94
16119.73
JP MORGAN
008-35008
000000079
ZBUT11V806EZRVTWT807
47781.84
IMPERIAL CAPITAL
008-50397
000043744
549300I8X15KSI64Y307
19822.44
RBC DAIN RAUSCHER INC.
008-45411
000031194
549300LCO2FLSSVFFR64
5813.83
VIRTU FINANCIAL BD LLC
8-60815
000148390
54930088MP91YZQJT494
21969.49
UBS SECURITIES LLC
008-22651
000007654
T6FIZBDPKLYJKFCRVK44
25434.15
BTIG LLC
008-65473
000122225
549300GTG9PL6WO3EC51
50031.33
BLAIR, WILLIAM, & COMPANY, L.L.C.
008-02698
000001252
549300J0P7XYE8BMZ775
4881.69
MISCHLER FINANCIAL
8-48067
000037818
2549004IPXPSM9EJFC92
116483.59
311834.92
0.00
N
1251872894.99
N
N
N
KPOP and Korean Entertainment ETF
S000076793
549300XJ30PASCLTXR72
Y
1
0
0
Exchange-Traded Fund
N
N
1.6
0.88
3.22244893
3.172322975
N
N
N
N
N/A
0.00000000
0.00000000
Rule 32a-4 (17 CFR 270.32a-4)
Rule 6c-11 (17 CFR 270.6c-11)
N
N
N
N
Exchange Traded Concepts, LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
The Bank of New York Mellon
085-05006
HPFHU0OQ28E4N0NFVK49
N
N
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
Bloomberg
254900BF4G8VMW8GG471
N
S&P
549300U4VWNITEKO2881
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N
SEI INVESTMENTS GLOBAL FUNDS SERVICES
801-24593
N
N
N
MISCHLER FINANCIAL
8-48067
000037818
2549004IPXPSM9EJFC92
4679.30999999
4679.30999999
0.00000000
N
2470742.75999999
N
N
N
Nifty India Financials ETF
S000068816
5493002SQJ8SYE3VG403
N
1
0
0
Exchange-Traded Fund
N
N
-1.59
-2.37
1.768823641
1.739144743
Y
N
N
N
N/A
0.00000000
0.00000000
Rule 6c-11 (17 CFR 270.6c-11)
Rule 32a-4 (17 CFR 270.32a-4)
N
N
N
N
Exchange Traded Concepts, LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
BROWN BROTHERS HARRIMAN & CO.
084-60256
5493006KMX1VFTPYPW14
N
N
N
S&P
549300U4VWNITEKO2881
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
Bloomberg
254900BF4G8VMW8GG471
N
IHS Markit
549300HLPTRASHS0E726
GB
N
N
BROWN BROTHERS HARRIMAN & CO.
5493006KMX1VFTPYPW14
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
BROWN BROTHERS HARRIMAN & CO.
5493006KMX1VFTPYPW14
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
N
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
MISCHLER FINANCIAL
8-48067
000037818
2549004IPXPSM9EJFC92
171.20999999
BTIG LLC
008-65473
000122225
549300GTG9PL6WO3EC51
2508.58999999
2679.79999999
0.00000000
N
7870192.84999999
N
N
N
KPOP and Korean Entertainment ETF
S000076793
N
10000.00000000
100.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
700.00000000
0.00000000
0.00000000
700.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
N
Nifty India Financials ETF
S000068816
N
25000.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
N
ROBO Global(R) Artificial Intelligence ETF
S000065729
Y
25000.00000000
6.41593843
0.17394298
93.58406156
0.17394298
5.59090997
0.34417552
94.40909002
0.34417552
0.00000000
550.00000000
0.00000000
0.00000000
550.00000000
0.00000000
0.00000000
550.00000000
0.00000000
0.00000000
550.00000000
0.00000000
Y
ROBO Global(R) Robotics and Automation Index ETF
S000042659
Y
25000.00000000
14.27609594
1.74750229
85.72390405
1.74750229
9.69702480
2.66122556
90.30297519
2.66122556
0.00000000
941.17647058
0.00000000
0.00000000
941.17647058
0.00000000
0.00000000
974.35897435
0.00000000
0.00000000
974.35897435
0.00000000
N
ROBO Global(R) Healthcare Technology and Innovation ETF
S000065730
Y
25000.00000000
2.50377627
0.90531531
97.49622372
0.90531531
1.07750874
0.26383873
98.92249125
0.26383873
0.00000000
412.50000000
0.00000000
0.00000000
550.00000000
0.00000000
0.00000000
515.62500000
0.00000000
0.00000000
0.00000000
0.00000000
Y
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
INDF_ICL.txt
INTERNAL CONTROL LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders of Nifty India Financials ETF and
Board of Trustees of Exchange Traded Concepts Trust
In planning and performing our audit of the financial statements of Nifty India
Financials ETF (the "Fund"), a series of Exchange Traded Concepts Trust, as of
and for the year ended April 30, 2023, in accordance with the standards of
the Public Company Accounting Oversight Board (United States) (PCAOB), we
considered the Fund's internal control over financial reporting, including
controls over safeguarding securities, as a basis for designing our auditing
procedures for the purpose of expressing our opinion on the financial
statements and to comply with the requirements of Form N-CEN, but not for
the purpose of expressing an opinion on the effectiveness of the Fund's
internal control over financial reporting. Accordingly, we express no such
opinion.
The management of the Fund is responsible for establishing and maintaining
effective internal control over financial reporting. In fulfilling this
responsibility, estimates and judgments by management are required to
assess the expected benefits and related costs of controls. A fund's internal
control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally
accepted accounting principles (GAAP). A fund's internal control over
financial reporting includes those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the fund; (2)
providereasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with GAAP, and that
receipts and expenditures of the fund are being made only in accordance
with authorizations of management and trustees of the fund; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of a fund's assets that could have
a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may
become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists when the
designor operation of a control does not allow management or employees, in
the normal course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or
combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of
the Fund's annual or interim financial statements will not be prevented or
detected on a timely basis.
Our consideration of the Fund's internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control that might be
materialweaknesses under standards established by the PCAOB. However, we
noted no deficiencies in the Fund's internal control over financial reporting
and its operation, including controls over safeguarding securities, that we
consider to be a material weakness as defined above as of April 30, 2023.
This report is intended solely for the information and use of management and
the Board of Trustees of the Fund and the Securities and Exchange
Commission and is not intended to be and should not be used by anyone
other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
June 23, 2023
INTERNAL CONTROL RPT
3
KPOP_ICL.txt
INTERNAL CONTROL LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders of KPOP and Korean Entertainment ETF and
Board of Trustees of Exchange Traded Concepts Trust
In planning and performing our audit of the financial statements of KPOP and
Korean Entertainment ETF (the "Fund"), a series of Exchange Traded
Concepts Trust, as of and for the period from September 1, 2022
(commencement of operations) through April 30, 2023, in accordance with
the standards of the Public Company Accounting Oversight Board (United
States) (PCAOB), we considered the Fund's internal control over financial
reporting, including controls over safeguarding securities, as a basis for
designing our auditing procedures for the purpose of expressing our opinion
on the financial statements and to comply with the requirements of Form N-
CEN, but not for the purpose of expressing an opinion on the effectiveness of
the Fund's internal control over financial reporting. Accordingly, we express
no such opinion.
The management of the Fund is responsible for establishing and maintaining
effective internal control over financial reporting. In fulfilling this
responsibility, estimates and judgments by management are required to
assess the expected benefits and related costs of controls. A fund's internal
control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally
accepted accounting principles (GAAP). A fund's internal control over
financial reporting includes those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the fund; (2)
providereasonable assurance that transactions are recorded as necessary to
permitpreparation of financial statements in accordance with GAAP, and that
receipts and expenditures of the fund are being made only in accordance
with authorizations of management and trustees of the fund; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of a fund's assets that could have
a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may
become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists when the
designor operation of a control does not allow management or employees, in
the normal course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or
combination of deficiencies, in internal control over financial reporting,
suchthat there is a reasonable possibility that a material misstatement of
the Fund's annual or interim financial statements will not be prevented or
detected on a timely basis.
Our consideration of the Fund's internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control that might be
material weaknesses under standards established by the PCAOB. However, we
noted no deficiencies in the Fund's internal control over financial reporting
and its operation, including controls over safeguarding securities, that we
consider to be a material weakness as defined above as of April 30, 2023.
This report is intended solely for the information and use of management and
the Board of Trustees of the Fund and the Securities and Exchange
Commission and is not intended to be and should not be used by anyone
other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
June 23, 2023
INTERNAL CONTROL RPT
4
ROBO_ICL.txt
INTERNAL CONTROL LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders of ROBO Global Healthcare Technology and Innovation
ETF, ROBO Global Robotics and Automation Index ETF, and ROBO Global
Artificial Intelligence ETF and
Board of Trustees of Exchange Traded Concepts Trust
In planning and performing our audit of the financial statements of ROBO
Global Healthcare Technology and Innovation ETF, ROBO Global Robotics and
Automation Index ETF, and ROBO Global Artificial Intelligence ETF (the
"Funds"), each a series of Exchange Traded Concepts Trust, as of and for the
year ended April 30, 2023, in accordance with the standards of the Public
Company Accounting Oversight Board (United States) (PCAOB), we
considered the Funds' internal control over financial reporting, including
controls over safeguarding securities, as a basis for designing our auditing
procedures for the purpose of expressing our opinion on the financial
statements and to comply with the requirements of Form N-CEN, but not for
the purpose of expressing an opinion on the effectiveness of the Funds'
internal control over financial reporting. Accordingly, we express no such
opinion.
The management of the Funds is responsible for establishing and maintaining
effective internal control over financial reporting. In fulfilling this
responsibility, estimates and judgments by management are required to
assess the expected benefits and related costs of controls. A fund's internal
control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally
accepted accounting principles (GAAP). A fund's internal control over
financial reporting includes those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the fund; (2)
providereasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with GAAP, and that
receipts and expenditures of the fund are being made only in accordance
with authorizations of management and trustees of the fund; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of a fund's assets that could
havea material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may
become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists when the
designor operation of a control does not allow management or employees, in
the normal course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or
combination of deficiencies, in internal control over financial reporting,
suchthat there is a reasonable possibility that a material misstatement of
the Funds' annual or interim financial statements will not be prevented or
detected on a timely basis.
Our consideration of the Funds' internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control that might be
materialweaknesses under standards established by the PCAOB. However, we
noted no deficiencies in the Funds' internal control over financial reporting
and its operation, including controls over safeguarding securities, that we
consider to be a material weakness as defined above as of April 30, 2023.
This report is intended solely for the information and use of management and
the Board of Trustees of the Funds and the Securities and Exchange
Commission and is not intended to be and should not be used by anyone
other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
June 23, 2023